H.Amdt.717 - An amendment numbered 7 printed in Part B of House Report 116-334 to require an HHS study to identify conditions without an FDA-approved treatment where the development of a treatment would fill an unmet medical need for a serious or life-threatening condition or rare disease. Requires HHS to identify appropriate incentives that would lead to the development of such treatments.